Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.1mm RC, SLA? 16mm, Ti, Loxim: medical device reports filed with FDA

339 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

339
device reports naming the brand
0% of all MAUDE reports · about 50 a year
53
reports, 12 months to August 2026
72 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 339 reports that name the brand "BLT ?4.1mm RC, SLA? 16mm, Ti, Loxim" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

53 reports arrived in the 12 months to August 2026, down 26% from 72 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (82%), loss of osseointegration (16.5%) and fracture (0.3%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01325Sep 2021: 2Oct 2021: 2Nov 2021: 5Dec 2021: 12022Jan 2022: 4Feb 2022: 6Mar 2022: 0Apr 2022: 2May 2022: 8Jun 2022: 4Jul 2022: 2Aug 2022: 4Sep 2022: 3Oct 2022: 4Nov 2022: 5Dec 2022: 12023Jan 2023: 4Feb 2023: 3Mar 2023: 7Apr 2023: 4May 2023: 2Jun 2023: 1Jul 2023: 7Aug 2023: 4Sep 2023: 6Oct 2023: 16Nov 2023: 0Dec 2023: 22024Jan 2024: 4Feb 2024: 14Mar 2024: 4Apr 2024: 1May 2024: 2Jun 2024: 6Jul 2024: 8Aug 2024: 4Sep 2024: 11Oct 2024: 3Nov 2024: 5Dec 2024: 52025Jan 2025: 7Feb 2025: 4Mar 2025: 2Apr 2025: 0May 2025: 0Jun 2025: 25Jul 2025: 6Aug 2025: 4Sep 2025: 9Oct 2025: 3Nov 2025: 2Dec 2025: 42026Jan 2026: 3Feb 2026: 3Mar 2026: 2Apr 2026: 4May 2026: 1Jun 2026: 7Jul 2026: 8Aug 2026: 7

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

034672019: 1420192020: 1920202021: 3920212022: 4320222023: 5620232024: 6720242025: 6620252026: 352026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%339
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report92.3%313
Voluntary report0%0
User facility report0%0
Distributor report7.7%26
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate27882%62.8%
Loss of osseointegration5616.5%22.4%
Fracturea broken bone10.3%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis6318.6%
Painpain, site not specified5415.9%
Inflammationinflammation175%
Swelling/ edema154.4%
Abscessa collection of pus113.2%
Tissue damage113.2%
Hemorrhage/blood loss/bleeding82.4%
Swellingswelling72.1%
Hyperresponsive to stimuli61.8%
Hypersensitivity/allergic reaction30.9%
Fistula20.6%
Sinus perforation20.6%
Increased sensitivity10.3%
Numbnessnumbness10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.1mm RC, SLA? 16mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports3393,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer92.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.1mm RC, SLA? 16mm, Ti, Loxim reports

How many FDA reports name BLT ?4.1mm RC, SLA? 16mm, Ti, Loxim?

339 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 53 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (82%), loss of osseointegration (16.5%) and fracture (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (92.3%) and distributor reports (7.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.1mm RC, SLA? 16mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.